Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
Document Type
Article
Publication Date
4-26-2023
Publication Title
The Journal of urology
Keywords
california; santa monica; sjci; jwci; molecular imaging; positron-emission tomography; prostatic neoplasms
Abstract
PURPOSE: SPOTLIGHT (NCT04186845) evaluated diagnostic performance and safety of radiohybrid
MATERIALS AND METHODS: Men with prostate cancer recurrence underwent positron emission tomography/CT 50-70 minutes after intravenous administration of 296%±20% MBq
RESULTS: The overall
CONCLUSIONS:
Clinical Institute
Cancer
Department
Oncology
Department
Diagnostic Imaging
Recommended Citation
Jani, Ashesh B; Ravizzini, Gregory C; Gartrell, Benjamin A; Siegel, Barry A; Twardowski, Przemyslaw W; Saltzstein, Daniel; Fleming, Mark T; Chau, Albert; Davis, Phillip; Chapin, Brian F; and Schuster, David M, "Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)" (2023). Articles, Abstracts, and Reports. 7405.
https://digitalcommons.providence.org/publications/7405
